This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Menu
Book
Key Sessions
Phyllis Arthur
COVID-19 therapeutics: Modality, efficacy and implications for access
(BIO) Biotechnology Innovation Organization
keyboard_arrow_right

Day 4 - Live Sessions

keyboard_arrow_leftSearch & Filter
search

Day 4 - Live Sessions

search
On Demand
Networking
BIO-Europe Digital 2020 Networking: Introducing the 24/7 Café
    10:00 - 10:3030 mins
    Networking
    BIO-Europe Digital 2020 Networking: Long-lasting partnerships are like happy marriages
    • Urs Schleuniger - Global Head Alliance & Asset Management, Roche Pharma Partnering
    17:00 - 18:0060 mins
    Plenary
    COVID-19 therapeutics: Modality, efficacy and implications for access
    • Phyllis Arthur - VP, Infections Disease & Diagnostics Policy, (BIO) Biotechnology Innovation Organization
    • David Thomas - Director, Industry Research and Analysis, Biotechnology Industry Organization (BIO)
    • Richard Marsden - CEO, Synairgen
    • Stuart Peltz - Founder and CEO, PTC Therapeutics
    Day 3 - Live Sessions

    Get the latest news.
    As it happens

    Sign up to get the latest on the agenda and speakers.
    Filter
    Streams
    Formats
    Choose Day